ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
83,300
-2,300 (-2.69%)
Jul 11, 2025, 3:30 PM KST

ST Pharm Revenue

ST Pharm had revenue of 52.42B KRW in the quarter ending March 31, 2025, with 1.35% growth. This brings the company's revenue in the last twelve months to 274.45B, down -4.06% year-over-year. In the year 2024, ST Pharm had annual revenue of 273.75B, down -3.94%.

Revenue (ttm)
274.45B
Revenue Growth
-4.06%
P/S Ratio
6.12
Revenue / Employee
419.01M
Employees
655
Market Cap
1,678.74B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 273.75B -11.24B -3.94%
Dec 31, 2023 284.99B 35.67B 14.31%
Dec 31, 2022 249.32B 83.68B 50.52%
Dec 31, 2021 165.64B 41.53B 33.47%
Dec 31, 2020 124.11B 30.85B 33.08%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
PharmaResearch 392.31B
Peptron 4.30B
Revenue Rankings